The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

Overview of attention for article published in Leukemia, September 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 588,260 followers.

OPEN ACCESS:POL5551 mobilizes hematopoietic stem + progenitor cells with greater efficiency than Plerixafor http://t.co/gI6ZeZ60Ya #leukemia

OPEN ACCESS:POL5551 mobilizes hematopoietic stem + progenitor cells with greater efficiency than Plerixafor http://t.co/gI6ZeZ60Ya #leukemia

OPEN ACCESS:POL5551 mobilizes hematopoietic stem + progenitor cells with greater efficiency than Plerixafor http://t.co/gI6ZeZ60Ya #leukemia

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.